TD Private Client Wealth LLC Sells 138 Shares of Waters Corporation $WAT

TD Private Client Wealth LLC lowered its position in Waters Corporation (NYSE:WAT) by 13.9% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 858 shares of the medical instruments supplier’s stock after selling 138 shares during the period. TD Private Client Wealth LLC’s holdings in Waters were worth $299,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in WAT. OVERSEA CHINESE BANKING Corp Ltd increased its position in shares of Waters by 676.8% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 705,733 shares of the medical instruments supplier’s stock valued at $260,112,000 after buying an additional 614,877 shares in the last quarter. Alliancebernstein L.P. increased its position in shares of Waters by 15.7% in the 1st quarter. Alliancebernstein L.P. now owns 3,070,671 shares of the medical instruments supplier’s stock valued at $1,131,757,000 after buying an additional 416,669 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Waters by 93.3% in the 1st quarter. Wellington Management Group LLP now owns 572,823 shares of the medical instruments supplier’s stock valued at $211,125,000 after buying an additional 276,433 shares in the last quarter. Nuveen LLC bought a new stake in shares of Waters in the 1st quarter valued at $94,028,000. Finally, Vanguard Group Inc. increased its position in shares of Waters by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 7,272,252 shares of the medical instruments supplier’s stock valued at $2,680,334,000 after buying an additional 173,584 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on WAT shares. Scotiabank restated a “sector outperform” rating and issued a $465.00 price objective on shares of Waters in a research report on Friday, July 11th. Wall Street Zen downgraded Waters from a “buy” rating to a “hold” rating in a research note on Saturday, July 26th. Robert W. Baird cut their price target on Waters from $374.00 to $352.00 and set an “outperform” rating on the stock in a report on Wednesday, July 16th. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the stock a “hold” rating in a report on Tuesday, August 5th. Finally, Bank of America boosted their target price on Waters from $370.00 to $375.00 and gave the company a “neutral” rating in a research note on Thursday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Waters currently has an average rating of “Hold” and a consensus price target of $378.73.

Waters Trading Up 1.4%

Waters stock opened at $291.95 on Monday. The firm has a 50-day moving average of $295.07 and a 200-day moving average of $327.21. Waters Corporation has a one year low of $275.05 and a one year high of $423.56. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The company has a market cap of $17.38 billion, a price-to-earnings ratio of 26.33, a P/E/G ratio of 2.72 and a beta of 1.07.

Waters (NYSE:WAT) last posted its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 EPS for the quarter, topping analysts’ consensus estimates of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company had revenue of $771.33 million during the quarter, compared to the consensus estimate of $745.96 million. During the same period in the prior year, the business posted $2.63 EPS. The company’s quarterly revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, equities analysts expect that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.